NYSEAMERICAN:CPHI - China Pharma Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.2990 -0.01 (-3.24 %)
(As of 01/18/2019 04:00 PM ET)
Previous Close$0.2990
Today's Range$0.28 - $0.3350
52-Week Range$0.19 - $0.84
Volume906,013 shs
Average Volume412,815 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
China Pharma Holdings, Inc. develops, manufactures, and markets generic and branded pharmaceutical, and biochemical products to hospitals and private retailers in the People's Republic of China. The company offers products in the form of dry powder injectables, liquid injectables, tablets, capsules, cephalosporin oral solutions, and granules. The company's products include Cerebroprotein Hydroloysate injection to treat memory decline and attention deficit; Gastrodin injection for tiredness, loss of concentration, poor sleep, and traumatic syndromes of the brain; Propylgallate and Ozagrel Sodium to treat cerebral thrombosis, coronary heart disease, and after surgery complications; Alginic Sodium Diester injection for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Bumetanide to treat edema diseases; and Candesartan for hypertension. It also provides Roxithromycin dispersible tablets for pharyngitis and tonsillitis; Cefaclor dispersible tablets for tympanitis, lower respiratory tract infection, urinary tract infections, and skin/skin tissue infection; Cefalexin capsules for acute tonsillitis; Anhydroandrographolide for ischemic heart, cerebrovascular, and high lipoprotein blood diseases; Clarithromycin granules and capsules; and Naproxen Sodium and PseudophedrineHydrochlorida sustained release tablets. In addition, the company offers Hepatocyte growth-promoting factor, Tiopronin, Compound Ammonium Glycyrrhetate S, and Omeparzole for the treatment of digestive diseases. Further, it provides Vitamin B6 injection; and Granisetron Hydrochloride injection to treat nausea and vomiting caused by radiotherapy and chemotherapy during the treatment of malignant tumors. The company offers its products through distributors, as well as through its network of 16 sales offices and approximately 1,000 sales representatives. China Pharma Holdings, Inc. is headquartered in Haikou, the People's Republic of China.

Receive CPHI News and Ratings via Email

Sign-up to receive the latest news and ratings for CPHI and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange NYSEAMERICAN
Industry Drug Manufacturers - Major
Sub-IndustryN/A
SectorMedical
Current SymbolNYSEAMERICAN:CPHI
Previous SymbolNYSEMKT:CPHI
CUSIPN/A
Phone+86-898-66811730

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Employees276
OptionableNot Optionable

China Pharma (NYSEAMERICAN:CPHI) Frequently Asked Questions

What is China Pharma's stock symbol?

China Pharma trades on the New York Stock Exchange (NYSE)AMERICAN under the ticker symbol "CPHI."

How were China Pharma's earnings last quarter?

China Pharma Holdings, Inc. (NYSEAMERICAN:CPHI) released its quarterly earnings data on Thursday, November, 15th. The company reported ($0.04) earnings per share for the quarter. The firm had revenue of $2.30 million for the quarter. View China Pharma's Earnings History.

When is China Pharma's next earnings date?

China Pharma is scheduled to release their next quarterly earnings announcement on Tuesday, April 2nd 2019. View Earnings Estimates for China Pharma.

Has China Pharma been receiving favorable news coverage?

News coverage about CPHI stock has been trending somewhat positive this week, InfoTrie Sentiment Analysis reports. The research group identifies negative and positive press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of negative five to positive five, with scores closest to five being the most favorable. China Pharma earned a news impact score of 0.9 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 2.0 out of 10, indicating that recent press coverage is very unlikely to have an impact on the company's share price in the near term.

Are investors shorting China Pharma?

China Pharma saw a increase in short interest during the month of December. As of December 31st, there was short interest totalling 121,920 shares, an increase of 142.4% from the December 14th total of 50,290 shares. Based on an average trading volume of 273,698 shares, the days-to-cover ratio is presently 0.4 days. Currently, 0.6% of the shares of the stock are short sold. View China Pharma's Current Options Chain.

Who are some of China Pharma's key competitors?

Who are China Pharma's key executives?

China Pharma's management team includes the folowing people:
  • Ms. Zhilin Li, Pres, CEO, Chairman & Interim CFO (Age 66)
  • Ms. Yao Huang, Chief Technical Officer
  • Ms. Jian Yang, Sec. (Age 59)

Who are China Pharma's major shareholders?

China Pharma's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Virtu Financial LLC (0.22%).

Which institutional investors are buying China Pharma stock?

CPHI stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC.

How do I buy shares of China Pharma?

Shares of CPHI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is China Pharma's stock price today?

One share of CPHI stock can currently be purchased for approximately $0.2990.

What is China Pharma's official website?

The official website for China Pharma is http://www.chinapharmaholdings.com.

How can I contact China Pharma?

China Pharma's mailing address is 2Nd Floor, No. 17, Jinpan Road, Haikou, HAIKOU, HAN 570216, China. The company can be reached via phone at +86-898-66811730.


MarketBeat Community Rating for China Pharma (NYSEAMERICAN CPHI)

Community Ranking:  3.5 out of 5 (star star star half star)
Outperform Votes:  138 (Vote Outperform)
Underperform Votes:  60 (Vote Underperform)
Total Votes:  198
MarketBeat's community ratings are surveys of what our community members think about China Pharma and other stocks. Vote "Outperform" if you believe CPHI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CPHI will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/19/2019 by MarketBeat.com Staff

Featured Article: Federal Reserve

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel